MAIA Biotechnology Inc (MAIA)
3.28
+0.16
(+5.13%)
USD |
NYAM |
May 17, 16:00
3.28
0.00 (0.00%)
After-Hours: 20:00
MAIA Biotechnology Total Liabilities (Quarterly): 14.48M for March 31, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 14.48M |
| December 31, 2023 | 7.089M |
| September 30, 2023 | 4.253M |
| June 30, 2023 | 3.394M |
| March 31, 2023 | 3.991M |
| Date | Value |
|---|---|
| December 31, 2022 | 3.514M |
| September 30, 2022 | 2.456M |
| June 30, 2022 | 3.098M |
| March 31, 2022 | 2.431M |
| December 31, 2021 | 2.146M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.146M
Minimum
Dec 2021
14.48M
Maximum
Mar 2024
4.685M
Average
3.454M
Median
Total Liabilities (Quarterly) Benchmarks
| Cyclacel Pharmaceuticals Inc | 8.198M |
| Avid Bioservices Inc | 275.06M |
| Oragenics Inc | 1.798M |
| NeuBase Therapeutics Inc | 9.485M |
| Viking Therapeutics Inc | 33.63M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 8.716M |
| Shareholders Equity (Quarterly) | -5.765M |